TRITON SYSTEMS, INC. — Department of Defense STTR Phase II: DHA STTR PHASE II H2-0783 SEASPOT, A SYSTEM USING ELECTRODERMAL ACTIVITY SENSING TO PREDIC
TRITON SYSTEMS, INC. — STTR Phase II award from Department of Defense.
Phase II STTR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,299,875 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Tagged technology areas: Human Performance & Medical, Sensors & Sensor Fusion. Follow those hubs for open topics and peer winners in the same cluster.
Summary
Triton Systems received $1.3 million from the Defense Health Agency to develop SEASPOT, a system that uses skin electrical activity sensors to predict oxygen toxicity risks. This helps protect military personnel in high-oxygen environments like diving or aviation.
- Amount
- $1,299,875
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- STTR · Phase II
- NAICS
- 512110 · MOTION PICTURE AND VIDEO PRODUCTION
- Place of performance
- MA
- Period
- 2024-09-27 → 2027-01-26
Technology domains
Description
DHA STTR PHASE II H2-0783 SEASPOT, A SYSTEM USING ELECTRODERMAL ACTIVITY SENSING TO PREDICT OXYGEN TOXICITY